Xylose
Xylose (wood sugar) is a pentose monosaccharide used in the D-xylose absorption test to assess intestinal absorption function, where oral D-xylose is absorbed by the small intestine without requiring pancreatic digestion and excreted in urine, with reduced excretion indicating malabsorption syndromes. It is also used as a low-calorie sweetener in some pharmaceutical formulations and as a substrate in diagnostic tests for bacterial overgrowth. In COPD research, inhaled xylose aerosols have been studied for mucociliary clearance assessment.
分子量
150.1300 g/mol
LogP
-2.50
TPSA
90.20 Ų
リピンスキーの五則
適合
治療領域
作用機序
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
2D構造
Cite this structure
Embed this structure
SMILES
O=C[C@H](O)[C@@H](O)[C@H](O)CO
InChI
InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1
Molecular Formula
C5H10O5
HBD / HBA
4 / 5
回転可能結合数
0
重原子数
10
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
Xylose (wood sugar) is a pentose monosaccharide used in the D-xylose absorption test to assess intestinal absorption function, where oral D-xylose is absorbed by the small intestine without requiring pancreatic digestion and excreted in urine, with reduced excretion indicating malabsorption syndromes. It is also used as a low-calorie sweetener in some pharmaceutical formulations and as a substrate in diagnostic tests for bacterial overgrowth. In COPD research, inhaled xylose aerosols have been studied for mucociliary clearance assessment.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Xylose is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1236821. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 135191. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="xylose"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/xylose/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/xylose/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/xylose/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="xylose"></drugfyi-drug>